HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

a study on Liver Transplant Acute Lymphoblastic Leukemia

Summary

Eligibility
for people ages 18-25 (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Sharad Wadhwani, MD, MPH (ucsf)
Headshot of Sharad Wadhwani
Sharad Wadhwani

Description

Summary

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Keywords

Liver Transplant; Complications, Pediatric ALL, Health Advocate, Patient Navigator

Eligibility

You can join if…

Open to people ages 18-25

  1. Patient has received a liver transplant >1 year ago
  2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
  3. Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.0.
  4. Patient will be transferred to adult transplant team in <6 months.
  5. Patient can read and write English or Spanish
  6. Patient is between 18-25 years old and can provide informed consent.
  7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

You CAN'T join if...

  • Patient has significant cognitive impairment.
  • Does not meet age criteria
  • Patient is a ward of the state.
  • Non-English, non-Spanish speakers.
  • Non-US residents.

Locations

  • University of California San Francisco accepting new patients
    San Francisco California 94158 United States
  • Children's Healthcare of Atlanta not yet accepting patients
    Atlanta Georgia 30345 United States

Lead Scientist at University of California Health

  • Sharad Wadhwani, MD, MPH (ucsf)
    Dr. Wadhwani is a practicing pediatric general/transplant hepatologist who specializes in caring for children across the entire spectrum of liver disease, from diagnosis to transplant. Dr. Wadhwani is also a clinical investigator with a research program dedicated to improving the lives of children undergoing liver transplant.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06386198
Study Type
Interventional
Participants
Expecting 20 study participants
Last Updated